Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Abiraterone is under clinical development by Austhera BioSciences and currently in Phase II for Hormone-Sensitive Prostate Cancer.

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

One of the most widespread myths about prostate cancer is that it only affects older men. While it is true that the risk of ...

Dalpiciclib is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Hormone-Sensitive Prostate Cancer.

understanding and recognizing potential warning signs can lead to earlier detection and more effective treatment outcomes.

Source Reference: Gudenkauf LM, et al "Balancing hormone therapy: Mitigating adverse effects of androgen-deprivation therapy and exploring alternatives in prostate cancer management" Am Soc Clin ...

4, 2024 — A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay disease ...

King Charles is holding steady with his cancer treatment. PEOPLE reports that palace sources say his treatments will continue ...

King Charles ’ health is on the mend. After being diagnosed with cancer last February, the monarch, 76, began undergoing ...